Karen Lewis - Chief People Officer at Apellis Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief People Officer
Issuer Symbol
APLS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Karen Lewis since 12 Mar 2025

Holdings reported by Karen Lewis for Apellis Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 70,251 $2,074,062 $29.52 29 Jan 2025 Direct

Transactions reported by Karen Lewis for Apellis Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.